IL6 and Cachexia: Initial patient responses to Toci treatment were favorable in two cancer cachexia patients with elevated IL-6 as well, demonstrating an increase in performance scores and enabling further chemotherapy treatment [134]; however, clinical trials have not been completed to fully examine the effectiveness of Toci in cancer cachexia patients [100].